POTENTIAL RE-RATE CATALYST EVENT: RESULTS, page-30

I think you need to take a better look at the history of EYE and capital raises, as someone who has been here for many years perhaps I can help with this? As TA said, Nova Eye Medical is not the cash burning type. If you look back at their history, capital raise announcements are very rare. They run their business very conservatively, even paying themselves quite low salaries compared to most other ASX stocks. In the Ellex days institutional investors even complained they didn't spend enough on growth, which was part of the reason for them selling Ellex and focusing on the high growth segments. The past two years have been different than usual, perhaps reflective of a major transformation this company is undergoing, which is naturally going to be expensive. They did one raise for the launch in March 2023, and another for growth in March 2024. I highly doubt they are going to do another raise 3 months later, I wouldn't even expect that for one of your usual cash burning mining dogs. The approaching report should give us a good idea of this though. As long as growth is maintained or even increased you can cross off the chance of a capital raise from your list. I believe they even said they should be fully funded to cash flow positive.